Tañeza, Ellan S.
HRN: 22-40-80 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/02/2023
CEFUROXIME 1.5GM (VIAL)
01/02/2023
01/09/2023
IV
1.5g
Q8hours
UTI; URTI
Waiting Final Action